| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |